HFA Premium Access

Safety and proof of biological activity support clinical development of AT-001 for diabetic cardiomyopathy: a phase 1/2 study

Congress Presentation

About the speaker

Doctor Riccardo Perfetti

New York (United States of America)
2 presentations
0 follower

14 more presentations in this session

STADE-HF: A Titration based on sST2 is safe but failed to decrease readmissions in patients admitted for acute heart failure.

Speaker: Mr J. Nicoleau (Montpellier, FR)

Thumbnail

Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre

Speaker: Miss S. Lyu (Beijing, CN)

Thumbnail

Interplay of stress regulatory transcription factors in human cardiac valvular disorders leading to heart failure and cross talk of NFAtc3 nuclear localization invitro.

Speaker: Professor I. Murtaza (Islamabad, PK)

Thumbnail

Who is taking care of decompensations of patients after a de novo AHF episode? An outlook on the natural history through the NOVICA cohort

Speaker: Doctor O. Miro (Barcelona, ES)

Thumbnail

Analysis on how the emergency physician decision of hospitalization or discharge home patients with acute heart failure matches with the risk categories stratified by the MEESSI scale

Speaker: Doctor O. Miro (Barcelona, ES)

Thumbnail

Access the full session

Clinical Forum - Sat.25 May 08:30 - Tues. 28 May at 12:30

Speakers: Doctor R. Perfetti, Mr J. Nicoleau, Miss S. Lyu, Professor I. Murtaza, Doctor O. Miro...
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations